Literature DB >> 28176257

Left ventricular phase entropy: Novel prognostic predictor in patients with dilated cardiomyopathy and narrow QRS.

Naoaki Kano1, Takahiro Okumura2, Satoshi Isobe1, Akinori Sawamura1, Naoki Watanabe1, Kenji Fukaya1, Hiroaki Mori1, Ryota Morimoto1,3, Katsuhiko Kato4, Yasuko K Bando1, Toyoaki Murohara1.   

Abstract

BACKGROUND: The prognostic impact and pathophysiology of global left ventricular mechanical dyssynchrony (LVMD), namely mechanical dyssynchrony of whole left ventricle, as assessed by phase analysis of electrocardiographically gated (ECG-gated) myocardial perfusion SPECT has not been clearly elucidated in patients with dilated cardiomyopathy (DCM) and narrow QRS complex (<120 ms). METHODS AND
RESULTS: Forty-six patients with DCM underwent ECG-gated myocardial 99mTc-sestamibi perfusion SPECT and endomyocardial biopsy. LV phase entropy was automatically calculated using a phase analysis of ECG-gated myocardial perfusion SPECT. The patients were divided into two groups according to the median phase entropy value: low-phase entropy (<0.61) (N = 23: LE group) and high-phase entropy (≥0.61) (N = 23: HE group). In the Kaplan-Meier survival analysis, the event-free survival rate was significantly lower in the HE group (log-rank P = 0.015). Moreover, high-phase entropy was an independent predictor of adverse cardiac events (hazard ratio, 5.77%; 95% confidence interval, 1.02-108.32; P = 0.047). Interestingly, the mRNA expression levels of sarcoplasmic reticulum Ca2+-ATPase (SERCA2a) in endomyocardial biopsy specimens were significantly lower in the HE group (P = 0.015).
CONCLUSION: LV phase entropy, which may reflect impairment of Ca2+ handling caused by decreased SERCA2a mRNA levels, is a novel prognostic predictor in patients with DCM and narrow QRS complex.

Entities:  

Keywords:  SERCA2a; cardiomyopathy; dyssynchrony; gated SPECT; outcomes research

Mesh:

Substances:

Year:  2017        PMID: 28176257     DOI: 10.1007/s12350-017-0807-1

Source DB:  PubMed          Journal:  J Nucl Cardiol        ISSN: 1071-3581            Impact factor:   5.952


  29 in total

1.  Improved Long-Term Prognosis of Dilated Cardiomyopathy With Implementation of Evidenced-Based Medication - Report From the CHART Studies - .

Authors:  Ryoichi Ushigome; Yasuhiko Sakata; Kotaro Nochioka; Satoshi Miyata; Masanobu Miura; Soichiro Tadaki; Takeshi Yamauchi; Kenjiro Sato; Takeo Onose; Kanako Tsuji; Ruri Abe; Jun Takahashi; Hiroaki Shimokawa
Journal:  Circ J       Date:  2015-04-02       Impact factor: 2.993

Review 2.  Reverse remodelling in heart failure with cardiac resynchronisation therapy.

Authors:  M St John Sutton; M G Keane
Journal:  Heart       Date:  2006-04-27       Impact factor: 5.994

3.  Adrenergic control of the force-frequency and relaxation-frequency relations in patients with hypertrophic cardiomyopathy.

Authors:  H Izawa; M Yokota; Y Takeichi; M Inagaki; K Nagata; M Iwase; T Sobue
Journal:  Circulation       Date:  1997-11-04       Impact factor: 29.690

4.  Quantification of myocardial perfusion SPECT using freeware package (cardioBull).

Authors:  Koichi Okuda; Kenichi Nakajima; Tetsuo Hosoya; Takehiro Ishikawa; Shinro Matsuo; Masaya Kawano; Junichi Taki; Seigo Kinuya
Journal:  Ann Nucl Med       Date:  2011-06-23       Impact factor: 2.668

5.  Relation of 99mTc-sestamibi washout with myocardial properties in patients with hypertrophic cardiomyopathy.

Authors:  Satoshi Isobe; Satoru Ohshima; Kazumasa Unno; Hideo Izawa; Katsuhiko Kato; Akiko Noda; Akihiro Hirashiki; Toyoaki Murohara
Journal:  J Nucl Cardiol       Date:  2010-07-16       Impact factor: 5.952

6.  Classification of the cardiomyopathies: a position statement from the European Society Of Cardiology Working Group on Myocardial and Pericardial Diseases.

Authors:  Perry Elliott; Bert Andersson; Eloisa Arbustini; Zofia Bilinska; Franco Cecchi; Philippe Charron; Olivier Dubourg; Uwe Kühl; Bernhard Maisch; William J McKenna; Lorenzo Monserrat; Sabine Pankuweit; Claudio Rapezzi; Petar Seferovic; Luigi Tavazzi; Andre Keren
Journal:  Eur Heart J       Date:  2007-10-04       Impact factor: 29.983

7.  Automatic global and regional phase analysis from gated myocardial perfusion SPECT imaging: application to the characterization of ventricular contraction in patients with left bundle branch block.

Authors:  Serge D Van Kriekinge; Hidetaka Nishina; Muneo Ohba; Daniel S Berman; Guido Germano
Journal:  J Nucl Med       Date:  2008-10-16       Impact factor: 10.057

8.  Prevalence of QRS prolongation in a community hospital cohort of patients with heart failure and its relation to left ventricular systolic dysfunction.

Authors:  Roopinder Sandhu; Robert C Bahler
Journal:  Am J Cardiol       Date:  2004-01-15       Impact factor: 2.778

Review 9.  Left ventricular dyssynchrony assessment using myocardial single-photon emission CT.

Authors:  Prem Soman; Ji Chen
Journal:  Semin Nucl Med       Date:  2014-07       Impact factor: 4.446

Review 10.  Selecting patients for cardiac resynchronization therapy: electrical or mechanical dyssynchrony?

Authors:  Nathaniel M Hawkins; Mark C Petrie; Michael R MacDonald; Kerry J Hogg; John J V McMurray
Journal:  Eur Heart J       Date:  2006-03-09       Impact factor: 29.983

View more
  7 in total

1.  Left-ventricular mechanical dyssynchrony in the prognosis of dilated cardiomyopathy: Which parameter is more useful?

Authors:  Weihua Zhou; Guang-Uei Hung
Journal:  J Nucl Cardiol       Date:  2017-03-30       Impact factor: 5.952

2.  Stress myocardial perfusion gated-SPECT imaging in advanced chronic kidney disease.

Authors:  Pierre-Yves Marie; Patrick Rossignol
Journal:  J Nucl Cardiol       Date:  2018-10-22       Impact factor: 5.952

3.  Left ventricular mechanical dyssynchrony for CAD diagnosis: Does it have incremental clinical values?

Authors:  Zhixin Jiang; Weihua Zhou
Journal:  J Nucl Cardiol       Date:  2018-09-14       Impact factor: 5.952

4.  The clinical usefulness of phase analysis in detecting coronary artery disease using dipyridamole thallium-201-gated myocardial perfusion imaging with a cadmium-zinc-telluride camera.

Authors:  Wan-Ling Lin; Shan-Ying Wang; Yu-Chien Shiau; Yen-Wen Wu
Journal:  J Nucl Cardiol       Date:  2018-08-31       Impact factor: 5.952

5.  Low-dose dobutamine stress gated blood pool SPECT assessment of left ventricular contractile reserve in ischemic cardiomyopathy: a feasibility study.

Authors:  Vladimir V Shipulin; Sergey L Andreev; Andrew S Pryakhin; Andrew V Mochula; Alina N Maltseva; Svetlana I Sazonova; Vladimir M Shipulin; Samia Massalha; Konstantin V Zavadovsky
Journal:  Eur J Nucl Med Mol Imaging       Date:  2022-02-12       Impact factor: 10.057

6.  Left ventricular mechanical dyssynchrony analzyed by Tc-99m sestamibi SPECT and F-18 FDG PET in patients with ischemic cardiomyopathy and the prognostic value.

Authors:  Yi Tian; Min Zhao; Weilong Li; Ziwei Zhu; Hongzhi Mi; Xiang Li; Xiaoli Zhang
Journal:  Int J Cardiovasc Imaging       Date:  2020-06-03       Impact factor: 2.357

7.  Prognostic Value of Phase Analysis for Predicting Adverse Cardiac Events Beyond Conventional Single-Photon Emission Computed Tomography Variables: Results From the REFINE SPECT Registry.

Authors:  Keiichiro Kuronuma; Robert J H Miller; Yuka Otaki; Serge D Van Kriekinge; Marcio A Diniz; Tali Sharir; Lien-Hsin Hu; Heidi Gransar; Joanna X Liang; Tejas Parekh; Paul B Kavanagh; Andrew J Einstein; Mathews B Fish; Terrence D Ruddy; Philipp A Kaufmann; Albert J Sinusas; Edward J Miller; Timothy M Bateman; Sharmila Dorbala; Marcelo Di Carli; Balaji K Tamarappoo; Damini Dey; Daniel S Berman; Piotr J Slomka
Journal:  Circ Cardiovasc Imaging       Date:  2021-07-20       Impact factor: 7.792

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.